• Innovent filed a next-day disclosure return on Aug. 27, 2026 for share issuances from option exercises.
• Issued 182,021 new ordinary shares across Aug. 26-27, lifting issued share capital to 1,743,864,650 shares.
• Exercise prices disclosed included HKD 2.32, HKD 78.2, HKD 1.66, HKD 30.6, HKD 51.4.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovent Biologics Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12303574), on August 27, 2026, and is solely responsible for the information contained therein.